BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23673218)

  • 1. Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: a structure-activity study.
    Mott BT; He R; Chen X; Fox JM; Civin CI; Arav-Boger R; Posner GH
    Bioorg Med Chem; 2013 Jul; 21(13):3702-7. PubMed ID: 23673218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities.
    He R; Mott BT; Rosenthal AS; Genna DT; Posner GH; Arav-Boger R
    PLoS One; 2011; 6(8):e24334. PubMed ID: 21904628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique and highly selective anticytomegalovirus activities of artemisinin-derived dimer diphenyl phosphate stem from combination of dimer unit and a diphenyl phosphate moiety.
    He R; Forman M; Mott BT; Venkatadri R; Posner GH; Arav-Boger R
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4208-14. PubMed ID: 23774439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human cytomegalovirus replication by artemisinins: effects mediated through cell cycle modulation.
    Roy S; He R; Kapoor A; Forman M; Mazzone JR; Posner GH; Arav-Boger R
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3870-9. PubMed ID: 25870074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemisinin-derived dimer diphenyl phosphate is an irreversible inhibitor of human cytomegalovirus replication.
    He R; Park K; Cai H; Kapoor A; Forman M; Mott B; Posner GH; Arav-Boger R
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3508-15. PubMed ID: 22547612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers.
    Arav-Boger R; He R; Chiou CJ; Liu J; Woodard L; Rosenthal A; Jones-Brando L; Forman M; Posner G
    PLoS One; 2010 Apr; 5(4):e10370. PubMed ID: 20442781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artemisinins target the intermediate filament protein vimentin for human cytomegalovirus inhibition.
    Roy S; Kapoor A; Zhu F; Mukhopadhyay R; Ghosh AK; Lee H; Mazzone J; Posner GH; Arav-Boger R
    J Biol Chem; 2020 Oct; 295(44):15013-15028. PubMed ID: 32855235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication.
    Oiknine-Djian E; Weisblum Y; Panet A; Wong HN; Haynes RK; Wolf DG
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to new highly potent antileukemia, antiviral and antimalarial agents via hybridization of natural products (homo)egonol, thymoquinone and artemisinin.
    Çapcı Karagöz A; Reiter C; Seo EJ; Gruber L; Hahn F; Leidenberger M; Klein V; Hampel F; Friedrich O; Marschall M; Kappes B; Efferth T; Tsogoeva SB
    Bioorg Med Chem; 2018 Jul; 26(12):3610-3618. PubMed ID: 29887512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological Activities of Artemisinin Derivatives Beyond Malaria.
    Liu X; Cao J; Huang G; Zhao Q; Shen J
    Curr Top Med Chem; 2019; 19(3):205-222. PubMed ID: 30674260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Artemisinin-Derived Autofluorescent Compound BG95 Exerts Strong Anticytomegaloviral Activity Based on a Mitochondrial Targeting Mechanism.
    Wild M; Hahn F; Grau B; Herrmann L; Niesar A; Schütz M; Lorion MM; Ackermann L; Tsogoeva SB; Marschall M
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artemisinin-derived dimers from a chemical perspective.
    Çapcı A; Herrmann L; Sampath Kumar HM; Fröhlich T; Tsogoeva SB
    Med Res Rev; 2021 Nov; 41(6):2927-2970. PubMed ID: 34114227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of a novel series of artemisinin dimers with potent anticancer activity involving Sonogashira cross-coupling reaction.
    Buragohain P; Saikia B; Surineni N; Barua NC; Saxena AK; Suri N
    Bioorg Med Chem Lett; 2014 Jan; 24(1):237-9. PubMed ID: 24332623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
    Neyts J; De Clercq E
    Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of Artemisinin-Derived Dimers, Trimers and Dendrimers: Investigation of Their Antimalarial and Antiviral Activities Including Putative Mechanisms of Action.
    Fröhlich T; Hahn F; Belmudes L; Leidenberger M; Friedrich O; Kappes B; Couté Y; Marschall M; Tsogoeva SB
    Chemistry; 2018 Jun; 24(32):8103-8113. PubMed ID: 29570874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro combination of anti-cytomegalovirus compounds acting through different targets: role of the slope parameter and insights into mechanisms of Action.
    Cai H; Kapoor A; He R; Venkatadri R; Forman M; Posner GH; Arav-Boger R
    Antimicrob Agents Chemother; 2014; 58(2):986-94. PubMed ID: 24277030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artemisone demonstrates synergistic antiviral activity in combination with approved and experimental drugs active against human cytomegalovirus.
    Oiknine-Djian E; Bar-On S; Laskov I; Lantsberg D; Haynes RK; Panet A; Wolf DG
    Antiviral Res; 2019 Dec; 172():104639. PubMed ID: 31654672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel ring-contracted artemisinin dimers with potent anticancer activities.
    Zhang N; Yu Z; Yang X; Hu P; He Y
    Eur J Med Chem; 2018 Apr; 150():829-840. PubMed ID: 29597166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarial chemotherapy: orally curative artemisinin-derived trioxane dimer esters.
    Conyers RC; Mazzone JR; Tripathi AK; Sullivan DJ; Posner GH
    Bioorg Med Chem Lett; 2015 Jan; 25(2):245-8. PubMed ID: 25481079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide.
    Oh S; Kim BJ; Singh NP; Lai H; Sasaki T
    Cancer Lett; 2009 Feb; 274(1):33-9. PubMed ID: 18838215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.